xmlui.themes.about.link
Visualizar por autor "López López, Carlos"
Mostrando ítems 1-15 de 15
-
Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR
Llerena Santiago, Susana; García Díaz, Nuria; Curiel Del Olmo, Soraya; Agraz Doblas, Antonio Manuel; García Blanco, Agustín; Pisonero Fraga, Helena; Varela, María; Santibáñez Margüello, Miguel
; Almaraz, Carmen; Cereceda, Laura; Martínez, Nerea; Arias Loste, María Teresa; Puente, Ángela; Martín Ramos, Luis; Rodríguez de Lope López, Carlos; Castillo Suescun, Federico José; Cagigas Fernández, Carmen; Isidro, Pablo; López López, Carlos; [et al.] (Impact Journals, 2018)
-
Cytokines and lymphoid populations as potential biomarkers in locally and borderline pancreatic adenocarcinoma
González-Borja, Iranzu; Viúdez, Antonio; Alors-Pérez, Emilia; Goñi, Saioa; Amat, Irene; Ghanem, Ismael; Pazo-Cid, Roberto; Feliu, Jaimen; Alonso, Laura; López López, Carlos; Arrazubi, Virginia; Gallego, Javier; Pérez-Sanz, Jairo; Hernández-García, Irene; Vera, Ruth; Castaño, Justo P.; Fernández-Irigoyen, Joaquín; López López, Carlos (MDPI, 2022-12)
-
Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study
Vallejo Casas, Juan Antonio; Sambo, Marcel; López López, Carlos; Durán-Poveda, Manuel; Rodríguez-Villanueva García, Julio; Santos, Rita Joana; Llanos, Marta; Navarro-González, Elena; Aller, Javier; Pubul, Virginia; Guadalix, Sonsoles; Crespo, Guillermo; González, Cintia; Zafón, Carles; Navarro, Miguel; Santamaría-Sandi, Javier; Segura, Ángel; Gajate, Pablo; Gómez-Balaguer, Marcelino; [et al.] (Bioscientifica Ltd., 2022)
-
Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial
García Alfonso P.; Elez E.; Soto Alsar J.; Páez D.; Fernández Montes, A.; Graña, B.; Salud, A.; Yubero, A.; Gómez España, M.A.; Macías, I.; Quintero, G.; López López, Carlos; Fernández Rodríguez T.; Grávalos, C.; González Flores, E.; Guix, M.; García Paredes, B.; Reina, J.J.; Rodríguez Mowbray, J.R.; [et al.] (BMJ, 2024)
-
ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA
Talamillo Cancelo, Cana; Grande González, Lara; Ruiz Ontañón, Patricia; Velásquez Rodríguez, Carlos José; Mollinedo, Pilar; Torices del Val, Silvia; Sánchez Gómez, Pilar; Aznar, Ángela; Esparis Ogando, Azucena; López López, Carlos; Lafita Navarro, María Carmen; Berciano Blanco, María Teresa; Montero Simón, Juan Antonio; Vázquez Barquero, Alfonso; Segura, Víctor; Villagra, Nuria T.; Pandiella, Atanasio; Lafarga Coscojuela, Miguel Ángel; León Serrano, Javier; [et al.] (Basingstoke : Nature Publishing Group, 2016-09-19)
-
Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study
Kudo, Masatoshi; Finn, Richard S; Qin, Shukui; Han, Kwang-Hyub; Ikeda, Kenji; Cheng, Ann-Lii; Vogel, Arndt; Tovoli, Francesco; Ueshima, Kazuomi; Aikata, Hiroshi; López López, Carlos; Pracht, Marc; Meng, Zhiqiang; Daniele, Bruno; Park, Joong-Won; Palmer, Daniel; Tamai, Toshiyuki; Saito, Kenichi; Dutcus, Corina E; [et al.] (Elsevier, 2023)
-
SEOM-GEMCAD-TTD clinical guidelines for the management of hepatocarcinoma patients (2023)
López López, Carlos; Calvo, Mariona; Cámara, Juan Carlos; García-Paredes, Beatriz; Gómez-Martín, Carlos; López, Ana María; Pazo-Cid, Roberto; Sastre, Javier; Yaya, Ricardo; Feliu, Jaime (Springer-Verlag Italia, 2024)
